IBT
CYTK icon

International Biotechnology Trust’s Cytokinetics CYTK Stock Holding History

International Biotechnology Trust’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.09M Hold
37,000
– – 0.37% 49
2023
Q2 		$1.21M Buy
+37,000
New +$1.37M 0.37% 44
2020
Q4 		– Sell
-25,000
Closed -$541K – 53
2020
Q3 		$541K Buy
+25,000
New +$585K 0.17% 50

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

International Biotechnology Trust's CYTK Position: Q3 2023 in Review

International Biotechnology Trust held its Cytokinetics (CYTK) position steady in Q3 2023 at 37,000 shares worth $1.09M. The position accounts for 0.37% of the portfolio, ranked #49.

International Biotechnology Trust first reported a position in CYTK in Q3 2020 and has held it in 3 quarters since. The position peaked at $1.21M in Q2 2023. 250 funds tracked by Wall St. Rank hold CYTK as of Q3 2023.

  • International Biotechnology Trust held 37,000 shares of Cytokinetics worth $1.09M as of Q3 2023.
  • International Biotechnology Trust left its Cytokinetics share count unchanged in Q3 2023.
  • Cytokinetics made up 0.37% of International Biotechnology Trust's portfolio in Q3 2023, its #49 holding.
  • International Biotechnology Trust first reported a position in Cytokinetics in Q3 2020 and has held it in 3 quarters since.
  • International Biotechnology Trust's Cytokinetics position peaked at $1.21M in Q2 2023.
  • 250 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.